Marc Clausse will take up his new role as Chief Commercial Officer at Santhera Pharmaceuticals (SIX: SANN) at the beginning of June. He succeeds Geert Jan van Daal, who is retiring.
https://european-biotechnology.com/wp-content/uploads/2026/05/eb.com_Marc_Clausse-_Santhera-scaled.jpg25602278Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2026-05-19 11:56:112026-05-19 11:56:11New CCO starts in June